CRNX CRINETICS PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Management Change Crinetics Pharmaceuticals announced the departure of COO James Hassard, who will provide consulting services for $200 per hour after his exit, along with a separation agreement that includes continued vesting of his equity awards until January 15, 2025.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC